[Form 4] L3Harris Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 highlights: On 07/29/2025 L3Harris Technologies (LHX) Chair & CEO Christopher E. Kubasik exercised 72,000 non-qualified stock options at an exercise price of $149.31 and simultaneously sold 72,000 common shares in the open market at a weighted-average price of $271.14 (range $269.92-$272.31). Following the transactions he now owns 145,577.82 shares directly and 30,000 shares indirectly through a grantor retained annuity trust.

The option, originally exercisable since 06/29/2019 and expiring 12/20/2027, was converted under code “M” (option exercise) and immediately disposed under code “S” (sale). The filing indicates routine reporting under Section 16 with no other derivative activity disclosed. Kubasik remains both a Director and the company’s Chair & CEO.

Key take-away: While the same-day sale represents sizeable insider monetization, the executive retains a meaningful equity stake that may continue to align his interests with shareholders.

Positive

• CEO retains 145,577.82 shares directly, plus 30,000 indirectly, indicating continued alignment with shareholder interests.
• Option exercise converts expiring incentive compensation, potentially reducing overhang from outstanding options.

Negative

• Sale of 72,000 shares at $271.14 represents a sizeable cash out (~equal to the exercised amount), which may be viewed as insider bearishness.
• Entire block sold immediately after exercise offers no incremental increase in insider ownership, possibly dampening confidence.

Insights

Securities Analyst

TL;DR: CEO sold 72k shares post-option exercise; still holds 145.6k shares—mixed signal.

The exercise price of $149.31 versus a sale at $271.14 suggests the options were well in the money, making liquidation economically rational ahead of expiry in 2027. Disposing of 72,000 shares (~$19.5 m gross) could raise concern about near-term valuation, but he continues to own roughly $40 m of stock (at current levels), tempering bearish interpretations. Because Form 4 shows a one-for-one exercise-and-sell, the net share count for Kubasik fell only modestly. Historically, similar transactions at LHX have not signaled fundamental deterioration. Overall impact: neutral-to-slightly negative for sentiment.

Corporate Governance Expert

TL;DR: Large but routine insider sale; ownership remains significant; governance risk low.

Executives often exercise options nearing mid-life to diversify and cover taxes; the simultaneous sale simplifies tax withholding. Kubasik’s remaining direct and indirect holdings exceed standard alignment thresholds, maintaining incentive congruence. No pledging or 10% ownership issues arise. Absent pattern sales or proximity to undisclosed events, the transaction appears procedural under the company’s trading policy. Thus, governance risk is limited and market impact should be contained.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

KUBASIK CHRISTOPHER E

(Last) (First) (Middle)

C/O L3HARRIS TECHNOLOGIES, INC.

1025 W. NASA BOULEVARD

(Street)

MELBOURNE FL 32919

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
L3HARRIS TECHNOLOGIES, INC. /DE/ [ LHX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair and CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, Par Value $1.00	07/29/2025		M		72,000	A	$149.31	217,577.82(1)	D
Common Stock, Par Value $1.00	07/29/2025		S		72,000	D	$271.14(2)	145,577.82	D
Common Stock, Par Value $1.00								30,000	I	By grantor retained annuity trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$149.31	07/29/2025		M			72,000	06/29/2019	12/20/2027	Common Stock, Par Value $1.00	72,000	$0	40,138	D

Explanation of Responses:

1. Includes 5.37 shares acquired through the Issuer's retirement plan based on information provided by the plan's administrators as of 6/27/2025.

2. Reflects the weighted average sale price (prices actually received ranged from $269.92 to $272.31). The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Remarks:

	By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik	07/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LHX CEO Christopher Kubasik report in the latest Form 4?

He exercised 72,000 stock options at $149.31 and sold the same number of shares at a weighted average price of $271.14.

How many LHX shares does the CEO now own?

After the transaction he holds 145,577.82 shares directly and 30,000 shares indirectly via a trust.

Was the transaction a routine option exercise?

Yes. Code “M” indicates an option exercise, and the option had been exercisable since 06/29/2019, expiring 12/20/2027.

Does the Form 4 suggest insider selling pressure on LHX stock?

The CEO did liquidate 72,000 shares, which can be perceived as negative, but he retains a substantial stake.

Were multiple price points involved in the sale?

Yes. The weighted average sale price was $271.14, with individual prices ranging from $269.92 to $272.31.